SpaceX secures the NASA StarBurst mission, reinforcing its dominance in the launch market through superior cash flow and a $93.5 billion balance sheet. While Rocket Lab offers significant growth potential through its upcoming Neutron rocket, its negative EBITDA and heavy dilution profile present higher risks for conservative portfolios.
Rocket Lab loses a NASA mission to SpaceX's Falcon 9 rideshare, and its negative EBITDA and dilution make it a riskier retirement investment.